Table 2

Baseline OCT results of patients with NMOSD and HCs.

Baseline
HC
Baseline
NMOSD
Baseline
EyesON- vs HC
Baseline
EyesON+ vs HC
Baseline
EyesON− vs EyesON+
Mean±SDEyesON- mean±SDEyesON+ mean±SDBSEP valuesBSEP valuesBSEP value
GCIP (mm3)0.63±0.040.59±0.060.43±0.12−0.040.010.002−0.190.02<2.0e−16 −0.150.027.4e−12
pRNFL (µm)98.5±9.296.7±11.967.0±24.2−2.512.590.330−30.224.605.0e−11 −27.914.547.9e−10
INL (mm3)0.27±0.030.27±0.030.28±0.04−0.010.010.340−0.0100.010.2500.0130.010.054
FT (µm)278±19267±21262±20−9.994.850.040−17.794.993.7e−4 −6.251.641.3e−4
TMV (mm3)2.37±0.102.25±0.152.11±0.19−0.140.036.1e−6 −0.270.043.7e−12 −0.110.021.0e−5
  • B, estimate; Eyes ON, patients with NMOSD without a history of ON; Eyes ON+, patients with NMOSD with a history of ON; FT, fovea thickness; GCIP, combined ganglion cell and inner plexiform layer; HC, healthy control; INL, inner nuclear layer; NMOSD, neuromyelitis optica spectrum disorders; OCT, optical coherence tomography; ON, optic neuritis; pRNFL, peripapillary retinal nerve fibre layer; TMV, total macular volume.